120 related articles for article (PubMed ID: 13243982)
21. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
BERNARD J; MATHE G; WEIL M
Sang; 1957; 28(1):80-2. PubMed ID: 13432604
[No Abstract] [Full Text] [Related]
22. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias.
MEZA ARRAU C; NIJAMKIN A
Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308
[No Abstract] [Full Text] [Related]
23. The immediate action of triethylene melamine in chronic lymphatic leuchaemia.
BOLTON JH; BEAN RH
Med J Aust; 1954 Sep; 2(12):474-8. PubMed ID: 13213377
[No Abstract] [Full Text] [Related]
24. [Triethylene melamine therapy of malignant granulomatosis and certain other malignant diseases].
HANSEN PB; BICHEL J
Nord Med; 1952 Jan; 47(2):58-61. PubMed ID: 14910945
[No Abstract] [Full Text] [Related]
25. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
KLIMA R; HORNISCHER R
Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
[No Abstract] [Full Text] [Related]
26. [Results of triethylene melanine therapy of Hodgkin's disease and of chronic myeloid leukemia; preliminary communication].
GARCIGA CE
Arch Cuba Cancerol; 1953; 12(1-6):39-46. PubMed ID: 13066241
[No Abstract] [Full Text] [Related]
27. [Triethylene melamine in Hodgkin's disease].
HOST H; QVIGSTAD G
Nord Med; 1955 Sep; 54(36):1383-5. PubMed ID: 13266133
[No Abstract] [Full Text] [Related]
28. ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
MORROW LB; ANDERSON RE
Arch Pathol; 1965 May; 79():484-93. PubMed ID: 14289001
[No Abstract] [Full Text] [Related]
29. Observations on the use of triethylene melamine in Hodgkin's disease.
DE ANDINO AM; ROMERO C; RIVERA J; RODRIGUEZ-MOLINA R
Bol Asoc Med P R; 1953 Apr; 45(4):107-18. PubMed ID: 13066528
[No Abstract] [Full Text] [Related]
30. [Thirty cases of chronic leukemic lymphadenosis treated with intravenous administration of triethylene melamine].
GIGANTE D; ZOPPINI A
Prog Med (Napoli); 1956 Jun; 12(12):361-8. PubMed ID: 13350408
[No Abstract] [Full Text] [Related]
31. Triethylene melamine in human malignant disease; results with oral administration of enteric-coated tablets.
PATERSON E; KUNKLER PB; WALPOLE AL
Br Med J; 1953 Jan; 1(4801):59-64. PubMed ID: 12997844
[No Abstract] [Full Text] [Related]
32. [Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].
MARTIN H
Klin Wochenschr; 1953 Mar; 31(11-12):263-6. PubMed ID: 13070457
[No Abstract] [Full Text] [Related]
33. [The therapeutic effect of triethylene melamine in hemoblastosis].
SCHULZE E; FRANKE R; THIELE FH
Arztl Wochensch; 1953 Jul; 8(29):690-4. PubMed ID: 13080055
[No Abstract] [Full Text] [Related]
34. [Association of intralymphatic radiotherapy and alkylating agents in the treatment of retroperitoneal hematosarcomas].
Bonadonna G; Chiappa S; Di Pietro S; Marano O; Molinari R; Uslenghi C
Nouv Rev Fr Hematol; 1967; 7(3):381-92. PubMed ID: 4229322
[No Abstract] [Full Text] [Related]
35. [Therapy of malignant diseases with triethylene melamine].
ROMEO ORBEGOZO JM
Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813
[No Abstract] [Full Text] [Related]
36. Triethylenemelamine and its associations in the treatment of hemolymphoblastoses and other neoplasms.
MARMONT A; FUSCO F
G Ital Chemioter; 1954; 1(1):193-5. PubMed ID: 13191624
[No Abstract] [Full Text] [Related]
37. [Early resistance to triethylene melamine].
LATTANZI A; PARDELLI G
Riforma Med; 1954 Jan; 68(1):7-12. PubMed ID: 13156339
[No Abstract] [Full Text] [Related]
38. [Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
BERNARD J; MATHE G; WEIL M
Rev Fr Etud Clin Biol; 1956 Dec; 1(10):1121-32. PubMed ID: 13408766
[No Abstract] [Full Text] [Related]
39. TRIETHYLENE MELAMINE IN THE CONTROL OF HODGKIN'S DISEASE AND THE LEUKEMIAS. IV. CLINICAL REPORTS, 1959-62.
SAMPEY JR
Am J Pharm Sci Support Public Health; 1963 Dec; 135():451-7. PubMed ID: 14101404
[No Abstract] [Full Text] [Related]
40. [Additional occurrence of carcinoma in a malignant disease treated with triethylene melamine].
LUHRS W; SCHAMMEL J; LOTZ HH
Z Gesamte Inn Med; 1954 Mar; 9(6):295-9. PubMed ID: 13170253
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
